Ascending Dose Study of Genome Editing by Zinc Finger Nuclease Therapeutic SB-FIX in Subjects With Severe Hemophilia B
Clinical trial NCT02695160 · TERMINATED
Trial details
- NCT number
- NCT02695160
- Sponsor
- Sangamo Therapeutics
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-15
- Primary completion
- 2021-04-19
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.